Glooko Highlights EndoTool Involvement at 2026 Mid-Atlantic Patient Safety Conference

According to a recent LinkedIn post from Glooko, the company will sponsor the 2026 Mid-Atlantic Patient Safety Conference organized by the Mid-Atlantic Patient Safety Center. The post highlights that Glooko plans to feature EndoTool, an inpatient glycemic management solution developed by Monarch Medical Technologies, a Glooko company.

The LinkedIn post suggests that EndoTool focuses on patient-specific insulin dosing that adapts dynamically to changing diabetes needs, with the goal of improving inpatient glycemic safety. For investors, this sponsorship may signal Glooko’s intent to deepen its presence in hospital settings, potentially supporting adoption of its inpatient offering and reinforcing its positioning in the clinical diabetes management segment.

By aligning EndoTool with a patient safety–focused event, Glooko appears to be targeting stakeholders concerned with hospital quality metrics and safety outcomes. If this visibility translates into hospital partnerships or expanded deployments, it could contribute to longer-term, recurring revenue streams tied to enterprise clinical workflows and support competitive differentiation versus other diabetes technology vendors.